Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
The Oncologist|September 4, 2007
Evolving strategies for combined-modality therapy for locally advanced head and neck cancerMarshall Posner
JAMA Oncology|April 6, 2023
Combination Immunotherapy in Head and Neck Cancer-Checkmate or a Draw?Marshall Posner
JAMA|March 13, 2025
Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx CancerMarshall Posner
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Clinical trials in squamous cell carcinoma of the head and neckMarshall Posner
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerRobert Haddad, Marshall Posner
AIDS Research and Human Retroviruses|May 26, 2004
Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assayLisa Cavacini, Marshall Posner
Cancer|March 11, 2003
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckRobert Haddad, Marshall Posner
Journal of the National Cancer Institute|December 19, 2015
Meaningful Questions in "Organ Preservation" - Past, Present, and FutureMarshall Posner, Vishal Gupta
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2015
Role of Prophylactic Bilateral Tonsillectomy as a Cancer Preventive StrategyKrzysztof Misiukiewicz, Marshall Posner
Nature Clinical Practice. Oncology|February 28, 2009
Targeting EGFR in head and neck cancer: a decade of progressChris Boshoff, Marshall Posner
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
The Oncologist|September 4, 2007
Evolving strategies for combined-modality therapy for locally advanced head and neck cancerMarshall Posner
JAMA Oncology|April 6, 2023
Combination Immunotherapy in Head and Neck Cancer-Checkmate or a Draw?Marshall Posner
JAMA|March 13, 2025
Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx CancerMarshall Posner
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Clinical trials in squamous cell carcinoma of the head and neckMarshall Posner
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerRobert Haddad, Marshall Posner
AIDS Research and Human Retroviruses|May 26, 2004
Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assayLisa Cavacini, Marshall Posner
Cancer|March 11, 2003
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckRobert Haddad, Marshall Posner
Journal of the National Cancer Institute|December 19, 2015
Meaningful Questions in "Organ Preservation" - Past, Present, and FutureMarshall Posner, Vishal Gupta
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2015
Role of Prophylactic Bilateral Tonsillectomy as a Cancer Preventive StrategyKrzysztof Misiukiewicz, Marshall Posner
Nature Clinical Practice. Oncology|February 28, 2009
Targeting EGFR in head and neck cancer: a decade of progressChris Boshoff, Marshall Posner
Pageof 10